Search results

  1. A

    Review Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map 2025 Todhunter-Brown et al

    Eventually found the map: https://www.journalslibrary.nihr.ac.uk/sites/journalslibrary/files/journal_data/BTBD8846/NIHR136262_supp7.html I could not use "Filters" on the page to arrive at the "11% of studies only included people with postexertional malaise" - using CCC I see 170 on the map...
  2. A

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    I certainly will, eventually ... takes time to go up these learning curves. I especially want to understand how these GWAS/WGS studies will infer possibly quite complex genotype-phenotype associations, and the corresponding multiple-test-corrections (dull statistical questions, but vital...
  3. A

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    Thanks so much - the "Efficiently Analyzing Large-Scale WGS Data" video is really helping.
  4. A

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    Epistasis (gene-gene interaction) seems an attractive hypotheses to explain at least part of GWAS "missing heritability". Is there a clear winner these days on how to do this? I read of efficient enumeration methods, random-forest and other ML methods, Bayesian methods, etc, but want to only...
  5. A

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    I guess I want to "look at" those technologies which GWAS results would prompt researchers to reach for next, in order to discover higher associations with PWME phenotypes. I read about Next-Gen GWAS methods, rare-variant-analysis etc, but as a non-scientist am confused as to which learning...
  6. A

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    Non-scientists like me are only now learning about the GWAS "missing heritability problem" (rare variants not on the GWAS arrays, epigenetics (SNPs affecting only gene expression), SNP/gene interactions) etc. I now have a better sense of how slight (but very important) a clue a significant SNP...
  7. A

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    Low SNP frequencies surprised my non-scientist eyes; for example, directly genotyped tagSNP rs115523291 had: a) Norwegian allele frequencies of 2.5% and 0.4% for MECFS/normal, P=8.5X10-07 b) UK 1.0% and 0.9% P=0.03 I take it...
  8. A

    Itaconate modulates immune responses via inhibition of peroxiredoxin 5, 2025, Tomas Paulenda et al

    May I give my non-scientist takeaway? a) interferons IFN make people feel lousy b) pathogen --> IFN secretion by macrophages ... some pathogen stimulates macrophages (eg microglial cells in the hypothalamus?) to produce itaconate (by expressing IRG1/ACOD1 enzyme) ... this occurs mainly in...
  9. A

    Psychosocial Nursing Diagnoses of Individuals With Myalgic Encephalomyelitis-Chronic Fatigue Syndrome: A Descriptive Study, 2025, Oter-Quintana et al

    We (society and medics) have surely evolved past all that. Fashioning psychosocial labelling seems to be backwards-looking and, in a way, actually reinforcing the very stigmas etc they profess to want to address. I can't see any benefit of this sort of labelling; to anyone.
  10. A

    Acute high-intensity exercise enhances T cell proliferation compared to moderate-intensity exercise, 2025, Siedlik et al

    Thanks - I guess if T cells are somehow impaired in ME then creating more impaired T cells is presumably not helpful for PEM.
  11. A

    Reactivated EBV, HHV6, HAdV in Sputum from ME/CFS Patients: Are autoAbs to IFN-I Impairing Antiviral Immunity?, 2025, Hannestad et al.

    High EBV but normal anti-IFN-1 autoAbs seems to support one pattern I keep coming back to: Epoch1. Prior to infection a) stress and “over-doing” things causes HPA activation to create sustained cortisol elevation b) high cortisol (initially may enhance innate immunity) if sustained can inhibit...
  12. A

    Review Advocating the role of trained immunity in the pathogenesis of ME/CFS; a mini review, 2025, Humer et al

    Could "trained immunity" not be triggered also by autoimmune disorders?
  13. A

    Review Advocating the role of trained immunity in the pathogenesis of ME/CFS; a mini review, 2025, Humer et al

    I noted that another thread "Defining trained immunity and its role in health and disease, 2020, Netea et al." elicited little response. Is "trained immunity" unlikely to be relevant to ME, and if so does anyone know of a good resource that explains/highlights why? Thanks so much.
  14. A

    Review Defining trained immunity and its role in health and disease, 2020, Netea et al.

    Do you think "trained immunity" is unlikely to be relevant to ME, and if so can you highlight the main issues? Are there other studies that do a better job of characterising the relationship, if any, between ME and "trained immunity"? Many thanks - I am keen to travel up this learning curve.
  15. A

    Hypothesis mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS, 2025, Bar-Tana

    While I have no scientific credentials in this area, I am alarmed to read Stressing ME mitochondria on the basis of a tenuous non-hypothesis implicating mTORC1 strikes me as a very bad idea.
Back
Top Bottom